(Q35070414)

English

Gemcitabine in transitional cell carcinoma of the urothelium

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

Europe PubMed Central

title

Gemcitabine in transitional cell carcinoma of the urothelium (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12597345

retrieved

6 August 2017

main subject

transitional cell carcinoma

1 reference

Hans von der Maase

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12597345

retrieved

6 August 2017

publication date

1 February 2003

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12597345

retrieved

6 August 2017

published in

Expert Review of Anticancer Therapy

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12597345

retrieved

6 August 2017

volume

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12597345

retrieved

6 August 2017

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12597345

retrieved

6 August 2017

page(s)

11-19

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12597345

retrieved

6 August 2017

cites work

Escalated MVAC with or without recombinant human granulocyte-macrophage colony-stimulating factor for the initial treatment of advanced malignant urothelial tumors: results of a randomized trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2F14737140.3.1.11

retrieved

21 January 2018

Weekly gemcitabine in advanced bladder cancer: a preliminary report from a phase I study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2F14737140.3.1.11

retrieved

21 January 2018

Gemcitabine monotherapy as second-line treatment in cisplatin-refractory transitional cell carcinoma - prognostic factors for response and improvement of quality of life

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2F14737140.3.1.11

retrieved

21 January 2018

Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2F14737140.3.1.11

retrieved

21 January 2018

Carboplatin-gemcitabine treatment of patients with transitional cell carcinoma of the bladder and impaired renal function

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2F14737140.3.1.11

retrieved

21 January 2018

Identifiers

DOI

10.1586/14737140.3.1.11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12597345

retrieved

6 August 2017

PubMed publication ID

12597345

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12597345

retrieved

6 August 2017

(Q35070414)

Gemcitabine in transitional cell carcinoma of the urothelium

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)